Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Plos One|April 14, 2020
Prevalence and burden of bronchiectasis in a lung cancer screening programMaria Sanchez-Carpintero Abad, Pablo Sanchez-Salcedo, Juan P de-Torres, et al.Diabetes Care|January 21, 2010
Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivityJosé Manuel Fernández-Real, Sergio Valdés, Melania Manco, et al.Journal of Thoracic Imaging|August 26, 2009
Low-dose volumetric computed tomography for quantification of emphysema in asymptomatic smokers participating in an early lung cancer detection trialGorka Bastarrika, Juan P Wisnivesky, Jesús C Pueyo, et al.Plos One|April 26, 2018
Pulmonary arterial enlargement predicts long-term survival in COPD patientsJuan P de-Torres, Ana Ezponda, Ana B Alcaide, et al.Chest|November 8, 2016
Clinical Features of Smokers With Radiological Emphysema But Without Airway LimitationAna B Alcaide, Pablo Sanchez-Salcedo, Gorka Bastarrika, et al.Respiratory Research|October 1, 2017
Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patientsJorge Zagaceta, Gorka Bastarrika, Javier J Zulueta, et al.Chest|October 16, 2025
Cardiovascular Events in COPD: Complementary Role of Cardiac Risk and Coronary Artery Calcium ScoresJuan P de-Torres, Ciro Casanova, Jorge Zagaceta, et al.Chest|December 15, 2007
Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chestJuan P de Torres, Gorka Bastarrika, Juan P Wisnivesky, et al.Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CTMaria J Garcia-Velloso, Gorka Bastarrika, Juan P de-Torres, et al.ERJ Open Research|July 1, 2021
Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trialArantza Campo, José María González-Ruiz, Enrique Andreu, et al.Pageof 3